(Q53333249)

13 May 2018

title

Cost-effectiveness analysis of pneumococcal vaccination of adults and elderly persons in Belgium. (English)

1 reference

13 May 2018

ORCID Public Data File 2021

0 references

1 reference

author name string

D De Graeve

series ordinal

1

1 reference

13 May 2018

G Lombaert

series ordinal

2

1 reference

13 May 2018

H Goossens

series ordinal

3

1 reference

13 May 2018

publication date

1 June 2000

1 reference

13 May 2018

published in

PharmacoEconomics

1 reference

13 May 2018

volume

17

1 reference

13 May 2018

issue

6

1 reference

13 May 2018

page(s)

591-601

1 reference

13 May 2018

https://scigraph.springernature.com/pub.10.2165/00019053-200017060-00005

exact match

0 references

cites work

[Trends in pneumococcal infections in Belgium from 1986 to 1991].

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00019053-200017060-00005

Pneumococcal vaccination in the prevention of community-acquired pneumonia: an optimistic view of cost-effectiveness.

21 January 2018

1 reference

12 December 2020

Cost-effectiveness of vaccination against pneumococcal bacteremia among elderly people

1 reference

12 December 2020

Inefficacy of pneumococcal vaccine in a high-risk population

1 reference

12 December 2020

Five‐Hundred Life‐Saving Interventions and Their Cost‐Effectiveness

1 reference

12 December 2020

A cost-benefit analysis of immunization for pneumococcal pneumonia

1 reference

12 December 2020

The protective efficacy of polyvalent pneumococcal polysaccharide vaccine.

1 reference

12 December 2020

Modern vaccines. Pneumococcus and influenza

1 reference

12 December 2020

Belgian consensus on pneumococcal vaccine. Working Party on Pneumococcal Vaccine

1 reference

12 December 2020

Cost effectiveness of vaccination against pneumococcal pneumonia

1 reference

12 December 2020

Pneumococcal vaccination. Controversies and opportunities

1 reference

12 December 2020

Pneumococcal vaccine. Efficacy and associated cost savings.

1 reference

12 December 2020

Community-acquired pneumonia

1 reference

12 December 2020

Pneumococcal bacteremia in Charleston County, South Carolina. A decade later.

1 reference

12 December 2020

Infections caused by Streptococcus pneumoniae: clinical spectrum, pathogenesis, immunity, and treatment

1 reference

12 December 2020

The Clinical Effectiveness of Pneumococcal Vaccine in the Elderly

1 reference

12 December 2020

Cost effectiveness of vaccination against pneumococcal pneumonia: an update

1 reference

12 December 2020

Efficacy of pneumococcal vaccination in adults. A meta-analysis of randomized controlled trials

1 reference

12 December 2020

Capsular types and antibiotic susceptibility of pneumococci isolated from patients in Belgium with serious infections, 1980-1993.

1 reference

12 December 2020

Pneumococcal vaccination by general practitioners: an evaluation of current practice

1 reference

12 December 2020

Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations

1 reference

12 December 2020

Use of vaccines for respiratory infections. Strategies for influenza and pneumococcal vaccines

1 reference

12 December 2020

Preventing pneumococcal bacteremia in patients at risk. Results of a matched case-control study

1 reference

12 December 2020

An overview of community acquired pneumonia with lessons learned from the British Thoracic Society Study.

1 reference

12 December 2020

The cost effectiveness of pneumococcal vaccination strategies

1 reference

12 December 2020

10.2165/00019053-200017060-00005

Identifiers

DOI

1 reference

13 May 2018

Dimensions Publication ID

1028742846

0 references

1 reference

13 May 2018